𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic Value

✍ Scribed by de Reijke, Theo M.; de Boer, Elizabeth C.; Kurth, Karl Heinz; Schamhart, Denis H.J.

Book ID
121769643
Publisher
Lippincott Williams and Wilkins
Year
1996
Tongue
English
Weight
715 KB
Volume
155
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Urinary interleukins in patients receivi
Urinary interleukins in patients receiving intravesical bacillus calmette-guerin therapy for superficial bladder cancer
✍ Jonathan D. Fleischmann; Zahra Toossi; Jerrold J. Ellner; Deborah B. Wentworth; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 668 KB

## Intravesical administration of Bacillus Calmette-Guerin (BCG) causes a localized cell-mediated immune response. The intensity of this inflammatory response may be gauged by measuring the levels of both interleukin-2 (IL-2) and an inhibitor of interleukin-2 (IL-2-IN) activity in the urine during

Urinary IL-2 assay for monitoring intrav
Urinary IL-2 assay for monitoring intravesical bacillus Calmette-GuΓ©rin response of superficial bladder cancer during induction course and maintenance therapy
✍ Fabien Saint; Nathalie Kurth; Pascale Maille; Dimitri Vordos; Andre Hoznek; Pasc πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 670 KB

## Abstract We evaluated the clinical significance of Th1(IL‐2)/Th2(IL‐10) urinary profiles during a weekly induction course lasting 6 weeks, followed by a weekly maintenance therapy schedule for 3 weeks. Urinary IL‐2 and /IL‐10 were measured by ELISA in 39 patients receiving BCG for superficial bl